解郁丸联合米氮平对产后抑郁症患者神经内分泌功能的影响

刘伟杰; 陈永新; 张瑞岭

解郁丸联合米氮平对产后抑郁症患者神经内分泌功能的影响

新乡医学院第二附属医院，河南新乡 453002

计量
- 文章访问数: 1498
- HTML全文浏览量: 2
- PDF下载量: 1213
- 被引次数: 0
出版历程
- 刊出日期: 2018-07-10

Effects of Jieyu Pill Combined with Mirtazapine on Neuroendocrine Function in Patients with Postpartum Depression

摘要

摘要: 目的观察解郁丸联合米氮平治疗产后抑郁症肝郁气滞证的临床疗效及对患者神经内分泌功能的影响。方法采用随机对照法将我院78例产后抑郁症肝郁气滞证患者随机分为对照组和治疗组，对照组给予米氮平治疗，治疗组给予米氮平和解郁丸治疗，疗程8周。于治疗前、治疗2、4、8周后观察并比较2组患者的爱丁堡产后抑郁量表（EPDS）、不良反应症状量表（TESS）评价总体疗效，并于治疗前及治疗8周后测定患者血清中单胺类神经递质5-羟色胺(5-HT)、去甲肾上腺素(NE)、雌二醇(E₂)及黄体酮（P）水平。结果对照组和治疗组的有效率分别为79.48%和92.31%（P<0.01）。治疗后2、4、8周与治疗前EPDS评分比较2组均明显降低（P<0.05~0.01），从治疗第2周末期起，治疗组的EPDS的评分与对照组的EPDS的评分比较明显下降（P<0.05~0.01）。治疗后2组患者血清中的5-HT、NE和E₂水平较治疗前明显升高，P水平较治疗前有明显降低（P<0.01），治疗组优于对照组（P<0.05~0.01）。对照组的不良反应总数9例（23.01%），TESS值为（6.41±0.57），治疗组的不良反应总例数4例（10.25%），TESS值为（3.10±0.29），2组TESS值比较差异有显著性意义（P＜0.05）。结论解郁丸联合米氮平治疗产后抑郁症肝郁气滞证的临床疗效佳，且不良反应少，并能有效地调整抑郁症患者5-HT、NE、E₂和P的水平，从而改善患者临床症状。
- 解郁丸 /
- 米氮平 /
- 产后抑郁症 /
- 神经内分泌
Abstract: OBJECTIVE To observe the clinical effect of Jieyu pill combined with mirtazapine in the treatment of patients with postpartum depression， and its impact on patients' neuroendocrine function. METHODS 78 patients with postpartum depression admitted in our hospital were randomly divided into the control group and the treatment group with random control method. The control group was treated with mirtazapine， and the treatment group was treated with mirtazapine combined with Jieyu pill， both groups were treated for eight weeks. Edinburgh postpartum depression scale (EPDS)， Treatment Emergent Symptom Scale (TESS) and the overall effects of two groups were observed and compared at pre-treatment， and 2， 4， 8 weeks after treatment. Levels of monoamine neurotransmitter 5-hydroxytryptamine(5-HT)， norepinephrine (NE)， estradiol (E₂) and progesterone (P) in patients' serum were measured at pre-treatment and 8 weeks after treatment. RESULTS The effective percentages of the control group and the treatment group were 79.48% and 92.31%， respectively (P<0.01). EPDS scores in two groups of 2， 4， 8 weeks after treatment were significantly decreased compared those of the pre-treatment. From the end of the 2nd week treatment， EPDS score in the treatment group was significantly decreased than that in the control group (P<0.01). Levels of 5-HT， NE and E₂ in patients' serum of two groups were increased significantly after treatment than those of the pre-treatment， and P level was decreased significantly than that of the pre-treatment (P<0.01). There were total 9 cases (23.01%) occurred adverse reactions in the control group， and the TESS value was （6.41±0.57）. There were total 4 cases (10.25%) occurred adverse reactions in the treatment group， and the TESS value was （3.10±0.29）. The TESS values in both groups were statistically significant (P<0.05). CONCLUSION Jieyu pill combined with mirtazapine has the satisfactory clinical effect for the treatment of postpartum depression with few adverse reactions. And it can effectively regulate the 5-HT， NE， E₂ and P levels of depression patients， and proceed to improve the clinical symptoms of patients.
- Jieyu pill /
- mirtazapine /
- postpartum depression /
- neuroendocrine

HTML全文

参考文献(18)

[1]	李凤艳，卢艳梅，郭敏．心理干预对产褥期抑郁症的影响[J]．中华全科医学，2014，12(2):252253.〖ZK)〗
[2]	张红宁．围产期护理干预预防产后抑郁症效果观察[J]．中国药物与临床，2015，15(5):736737.〖ZK)〗
[3]	朱春香．产后抑郁相关危险因素及护理研究进展[J]．上海护理，2014，14(2):7074.〖ZK)〗
[4]	中华医学会精神科学会．精神疾病分类方案与诊断标准[M].3版.济南:山东科技出版社，2001:61.〖ZK)〗
[5]	马秀华，宋风丽，康淑玲，等．爱丁堡产后抑郁量表在产后抑郁症筛查中的应用[J]．中国医刊，2017，52(2):5257.〖ZK)〗
[6]	国家中医药管理局．中医病症诊断疗效标准[M]．南京:南京大学出版社， 1994:20.〖ZK)〗
[7]	岳莉莉，左文秀，汪辉耀，等．度洛西汀和米氮平治疗老年抑郁症的临床比较[J]．国际精神病学杂志，2015，42(6):3740.〖ZK)〗
[8]	王奕權，陈露，滕青贤，等．乌灵胶囊联合舍曲林治疗产后抑郁的疗效观察及对体内雌、孕激素和孤啡肽的影响[J]．浙江中医药大学学报，2014，38(3):250254.〖ZK)〗
[9]	罗阳，朱丽明．产后抑郁症病因学研究进展[J]．中国妇产科临床杂志，2015，16(6):570573.〖ZK)〗
[10]	李苒，高杉，李琳，等．抑郁症发病机制的研究进展[J]．天津中医药，2013，30(2):121125.〖ZK)〗
[11]	王联生，黄世敬，潘菊华，等．解郁丸治疗抑郁症的随机对照试验的系统评价[J]．医学综述，2017，23(10):20462051.〖ZK)〗
[12]	马荣，钱瑞琴，姚海燕，等．解郁丸抗抑郁作用机制的初步研究[J]．中国实验方剂学杂志，2010，16(10):168174.〖ZK)〗
[13]	GLYNN LM，DAVIS EP，SANDMAN CA．New insights into the role of perinatal HPAaxis dysregulation in postpartum depression[J]． Neuropeptides， 2013， 47(6): 363370.〖ZK)〗
[14]	司天梅．米氮平在抑郁症治疗中的作用[J]．中华神经科杂志，2013，46(2)：116117.〖ZK)〗
[15]	周萍，陈欧娜，江琼，等．益肾养心疏肝汤联合针灸治疗女性更年期综合征的临床研究[J]．世界科学技术-中医药现代化，2014，16(5):11031107.〖ZK)〗
[16]	王瑛，付政，刘津予，等．产后抑郁症患者血清雌二醇、孕酮水平分析[J]．临床医学，2003，23(12):5859.〖ZK)〗
[17]	AHOKAS A，KAUKORANTA J， WAHLBECK K， et al. Transdeemaloestrogen for treatment of severe postnatal depression[J]. Lancet， 1996， 347:930933.〖ZK)〗
[18]	陆竹梅，林文秀．产后抑郁症患者雌、孕激素及催乳素变化的研究[J].华夏医学，2006，19(2):188189.〖ZK)〗